By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – SDIX today reported that its fourth-quarter revenues dipped 13 percent year over year, as its Life Science business dropped 11 percent.

For the period ended Dec. 31, 2011, total revenues were $5.5 million, down from $6.3 million a year ago. Life Science brought in revenues of $3.8 million, compared to $4.2 million in Q4 2010, a drop that the company attributed to order timing in the IVD business as larger orders were placed earlier during 2011.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.